Orelabrutinib Combined With Rituximab Versus R-CVP in the Untreated MZL: A Randomized, Open Phase II Trial
The First Affiliated Hospital of Nanchang University
The First Affiliated Hospital of Nanchang University
Henan Cancer Hospital
Universität des Saarlandes
National Cancer Institute (NCI)
SWOG Cancer Research Network
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center